Organogenesis Holdings Inc (ORGO)
2.285
-0.70
(-23.32%)
USD |
NASDAQ |
Apr 25, 16:00
2.285
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Total Liabilities (Quarterly): 181.36M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 181.36M |
| September 30, 2023 | 185.78M |
| June 30, 2023 | 179.03M |
| March 31, 2023 | 182.41M |
| December 31, 2022 | 183.69M |
| September 30, 2022 | 200.94M |
| June 30, 2022 | 201.97M |
| March 31, 2022 | 193.04M |
| December 31, 2021 | 201.92M |
| September 30, 2021 | 181.25M |
| June 30, 2021 | 176.64M |
| March 31, 2021 | 161.89M |
| December 31, 2020 | 148.41M |
| September 30, 2020 | 180.95M |
| June 30, 2020 | 180.74M |
| March 31, 2020 | 168.04M |
| Date | Value |
|---|---|
| December 31, 2019 | 165.10M |
| September 30, 2019 | 161.83M |
| June 30, 2019 | 144.88M |
| March 31, 2019 | 143.89M |
| December 31, 2018 | 116.64M |
| September 30, 2018 | 13.14M |
| June 30, 2018 | 16.75M |
| March 31, 2018 | 15.91M |
| December 31, 2017 | 157.28M |
| September 30, 2017 | 13.55M |
| June 30, 2017 | 10.94M |
| March 31, 2017 | 10.99M |
| December 31, 2016 | 11.33M |
| September 30, 2016 | 0.8526M |
| June 30, 2016 | 0.6097M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
144.88M
Minimum
Jun 2019
201.97M
Maximum
Jun 2022
177.89M
Average
180.95M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 460.02M |
| Shareholders Equity (Quarterly) | 278.66M |
| Debt to Equity Ratio | 0.2377 |
| Current Ratio | 2.795 |
| Net Debt Paydown Yield | 0.24% |